Nanophase Q3 revenue $7.9M up 80% YoY; nine-month net income $2.7M

SOLESENCE, INC.

2021-Q3 EPS reported $0.06 revenue$22,110,000

Q3 revenue $7.9M vs $3.9M YoY; nine-month revenue $22.1M vs $12.3M.
Nine-month net income $2.7M ($0.04 EPS gain) vs $0.8M in 2020.
Solésence beauty science nine-month revenue $13.4M, up 204% YoY, exceeding full-year 2020.
Personal Care Ingredients revenue $5.3M (+28%); Advanced Materials $3.4M (-8%).
Purchase orders in hand for $27M+; ~$10M applies to 2021 orders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.